Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Greenwich LifeSciences, Inc. (GLSI)

Abeona Therapeutics Inc. and Greenwich LifeSciences, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Greenwich LifeSciences, Inc. are of similar size ($238.5M and $222.7M). Greenwich LifeSciences, Inc. has the higher net margin (0.00% vs −242.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Greenwich LifeSciences, Inc. leads on 7 and Abeona Therapeutics Inc. on 6.

Valuation

Metric ABEO GLSI Biotechnology median
P/E n/m n/m 10.60
P/S 9.18 n/m 9.40
P/B 1.86 71.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.09 n/m 9.02
Earnings yield (28.06%) (9.95%) (32.88%)
Free cash flow yield (34.27%) (5.63%) (23.13%)

Profitability

Metric ABEO GLSI Biotechnology median
Gross margin 66.03% 0.00% 68.51%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (986.31%) (51.96%)
Return on assets (29.54%) (374.46%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABEO GLSI Biotechnology median
Revenue growth (TTM) 427.47% — 6.76%
EPS growth (last fiscal year) 165.16% (6.72%) 29.88%
Revenue growth, 5-year CAGR 14.19% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO GLSI Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 1.54 4.97
Net debt to EBITDA 2.00 0.32 1.01

Dividend

Metric ABEO GLSI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABEO GLSI Biotechnology median
Market cap 238.46m 222.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack